McKesson (MCK) Stock Price Target Lowered at Credit Suisse
NEW YORK (TheStreet) -- Credit Suisse lowered its price target on McKesson (MCK) - Get Report stock to $220 from $263 on Monday. The firm maintained its "outperform" rating on the stock.
The San Francisco-based healthcare technology company reported its fiscal 2016 second quarter earnings results last week. McKesson reported earnings of $3.31 per share, higher than analyst estimates of $3.27 per share.
McKesson has projected its fiscal 2016 earnings at $12.50 per share to $13 per share.
Credit Suisse analysts raised their fiscal 2016 earnings projections on McKessson to $12.78 per share from $12.64 per share.
Shares of McKesson closed up by 1.03% to $180.64 on Monday.
Separately, TheStreet Ratings team rates MCKESSON CORP as a Buy with a ratings score of B+. TheStreet Ratings Team has this to say about their recommendation:
We rate MCKESSON CORP (MCK) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.
You can view the full analysis from the report here: MCK
data by